azacitidine and Debility

azacitidine has been researched along with Debility in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alizadeh, AA; Beaven, AW; Brem, EA; Caimi, PF; Cerchietti, L; Dillon, H; Friedberg, JW; Henry, NL; Laubach, C; LeBlanc, M; Li, H; Little, RF; Olin, R; Smith, SM	1

Trials

1 trial(s) available for azacitidine and Debility

Article	Year
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospectiv Journal of geriatric oncology, 2022, Volume: 13, Issue:2 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Frailty; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prospective Studies; Rituximab	2022

Article

Year

SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospectiv

Journal of geriatric oncology, 2022, Volume: 13, Issue:2

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Frailty; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Prospective Studies; Rituximab

2022